Status:
COMPLETED
sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?
Lead Sponsor:
CHU de Reims
Conditions:
CORONAVIRUS INFECTIONS
Eligibility:
All Genders
18+ years
Brief Summary
Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis (Limit : 5000 characters) The management of critically-ill patients with organ failure ...
Detailed Description
Extended description of the protocol, including more technical information (as compared to the Brief Summary) if desired. Do not include the entire protocol; do not duplicate information recorded in o...
Eligibility Criteria
Inclusion
- Patient with documented COVID-19 (positive PCR)
- Hospitalized in University Hospital of Reims
- Patient or family who have previously consented
Exclusion
- Patient \<18 yo
- Patient not insured under the French social security
Key Trial Info
Start Date :
April 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04394195
Start Date
April 3 2020
End Date
September 1 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092